Repozytorium

Interactions of anti-Parkinson drug benserazide with Zn(II), Cu(II), Fe(II) ions.

Autorzy

Łukasz Szyrwiel

József Sándor Pap

Wiesław Malinka

Zbigniew Szewczuk

Aleksandra Kotynia

Justyna Brasuń

Rok wydania

2013

Czasopismo

Journal of Pharmaceutical and Biomedical Analysis

Numer woluminu

76

Strony

36-43

DOI

10.1016/j.jpba.2012.11.032

Kolekcja

Naukowa

Język

Angielski

Typ publikacji

Artykuł

Streszczenie

One of the treatments of Parkinson disease is based on increasing the brain dopamine level by L-DOPA (LD) applications. To prevent the peripheral degradation of levodopa, another drug, benserazide is applied. On the other hand, during this neurodegenerative disease changes in the homeostasis of metals are observed and the increasing brain zinc levels are postulated to have therapeutic effects. Here we present studies on interactions of Zn(II), Cu(II), Fe(II) ions with benserazide and with benserazide/levodopa in ternary system. By applying mass spectrometry and UV–vis methods we describe the interactions between selected metal ions and the drug additives in the investigated systems. The results show forming of equimolar complexes in the binary and ternary systems.

Słowa kluczowe

Interactions with metal ions, Stability, Benserazide, Mass spectrometry, Parkinson's disease

Adres publiczny

http://dx.doi.org/10.1016/j.jpba.2012.11.032

Strona internetowa wydawcy

http://www.elsevier.com

Podobne publikacje
2019

Evaluation of tryptic podocin peptide in urine sediment using LC-MS-MRM method as a potential biomarker of glomerular injury in dogs with clinical signs of renal and cardiac disorders.

Szczepankiewicz Barbara, Bąchor Remigiusz, Pasławski Robert, Siwińska Natalia, Pasławska Urszula, Konieczny Andrzej, Szewczuk Zbigniew

2010